Immunic of Germany Set For Nasdaq After Merger With Failed Vital Therapies

 
• By Kevin Grogan
  
GermanyUSACogs
Merger creates a US-German autoimmune specialist • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business